Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
about
The metabolic rate constants and specific activity of human and rat hepatic cytochrome P-450 2E1 toward toluene and chloroformToxicity testing in the 21st century: a vision and a strategyWhole-body physiologically based pharmacokinetic models.Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability.
P2860
Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Application of in vitro biotra ...... c modeling to risk assessment.
@ast
Application of in vitro biotra ...... c modeling to risk assessment.
@en
type
label
Application of in vitro biotra ...... c modeling to risk assessment.
@ast
Application of in vitro biotra ...... c modeling to risk assessment.
@en
prefLabel
Application of in vitro biotra ...... c modeling to risk assessment.
@ast
Application of in vitro biotra ...... c modeling to risk assessment.
@en
P2860
P1476
Application of in vitro biotra ...... c modeling to risk assessment.
@en
P2093
G L Kedderis
J C Lipscomb
P2860
P304
P356
10.1191/0748233701TH119OA
P407
P577
2001-06-01T00:00:00Z